Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial | The BMJ
Why tocilizumab could be an effective treatment for severe COVID-19? | Journal of Translational Medicine | Full Text
Anti‐interleukin‐6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases - Tanaka - 2011 - FEBS Letters - Wiley Online Library
Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease - ScienceDirect
Interleukin‑6 signaling blockade treatment for cytokine release syndrome in COVID‑19 (Review)
Clinical experience of IL-6 blockade in rheumatic diseases—Implications on IL-6 biology and disease pathogenesis - ScienceDirect
Frontiers | Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis | Pharmacology
Why tocilizumab could be an effective treatment for severe COVID-19? | Journal of Translational Medicine | Full Text
Tocilizumab in the treatment of adult rheumatoid arthritis | Immunotherapy
Treatment of Rheumatoid Arthritis with Biological Agents | IntechOpen
Actemra | Uses, Safety Info & Comparison to Other RA Drugs
About ACTEMRA® (tocilizumab) Treatment Info for Healthcare Professionals
Subcutaneous formulation of tocilizumab for treatment of rheumatoid arthritis | Therapeutic Delivery
Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19 - ScienceDirect
![The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/10322/1/fig-3-full.png "The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review [PeerJ]")
The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review [PeerJ]
Outlook of IL-6 signaling blockade for COVID-19 pneumonia | Inflammation and Regeneration | Full Text
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia | SpringerLink
Mechanism of action of tocilizumab in RA (bathtub theory). Notes: The... | Download Scientific Diagram
Figure 5 | The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid Arthritis
JCI - IL-6 polymorphisms: a useful genetic tool for inflammation research?
IJMS | Free Full-Text | Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence | HTML
Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis | Infectious Diseases of Poverty | Full Text
How is Actemra® (tocilizumab) for GCA believed to work?
A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases | SpringerLink
